Specifically, breast (23–25), ovarian (26), pancreatic (27), and nasopharyngeal cancers (28), have demonstrated that LIF overexpression by tumours contributes to tumor growth and metastasis as mediated by the STAT3 pathway. The gene discussed is STAT3; the disease is neoplasm.